HOXB9 and lung adenocarcinoma: In a large data set (461 cases for the TCGA), GalNAc-T14 and HOXB9 expression was apparently associated with an increased risk of poor overall survival and high recurrence in lung adenocarcinoma patients, indicating a possible clinical relevance for their involvement in metastasis.